The Effect of High Dose Vitamin C on the Liver Function in Chronic Hepatitis Patients
NCT ID: NCT01413360
Last Updated: 2016-07-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
10 participants
INTERVENTIONAL
2011-08-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hepatitis c and Vitamin D and Iron Status
NCT03166280
Q-Trial in Patients With Hepatitis C
NCT01438320
Impact of Metabolic Changes and Vitamin D Status on Virological Response in Patients With HCV Infection Treated by DAAs
NCT03820102
Exploring the Knowledge, Attitudes, Behaviors and Perceived Barriers of Hepatologists Towards Non-invasive Hepatocellular Carcinoma Prediction Models in Hepatitis C Patients Who Achieved Sustained Virological Response Following Direct Acting Antivirals Therapy
NCT06872047
A Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis C
NCT01705717
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HD Vitamin C
High dose vitamin C
High dose vitamin C
Vitamin C, 3g per day (tid), with meal, per oral with water 100mL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High dose vitamin C
Vitamin C, 3g per day (tid), with meal, per oral with water 100mL
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* positive anti-HCV antibody more than 6 months
* serum alanine aminotransferase 40 - 80 IU/L for more than 6 months
* not indicated for antiviral therapy with interferon and ribavirin
2. Chronic alcoholic hepatitis
* significant alcohol drinking history and no other cause of chronic hepatitis
* serum alanine aminotransferase 40 - 80 IU/L for more than 6 months
Exclusion Criteria
* decompensated liver cirrhosis
* platelet \< 50,000/uL or white blood cell \< 1,500/uL
* need and willing for antiviral therapy
* significant renal dysfunction (GFR \< 30 mL/min/kg) or history of renal stone
* hepatotonic drug (i.e. silymarin, garlic oil, aronamin gold) usage within 2 weeks
* pregnancy, lactating woman
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jung-Hwan Yoon
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jung-Hwan Yoon, M.D, Ph.D
Role: STUDY_DIRECTOR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VitC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.